The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 101–200 of 1,071
A cascade of arabinosyltransferases controls shoot meristem size in tomato
Xu, C., Liberatore, K. L., MacAlister, C. A., Huang, Z., Chu, Y.-H., Jiang, K., Brooks, C., Ogawa-Ohnishi, M., Xiong, G., Pauly, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3309 · Cited by 493
Synthetic biology to access and expand nature's chemical diversity
Smanski, M. J., Zhou, H., Claesen, J., Shen, B., Fischbach, M. A., & Voigt, C. A. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.24 · Cited by 481
Opportunities and Challenges for Catalysis in Carbon Dioxide Utilization
Burkart, M. D., Hazari, N., Tway, C. L., & Zeitler, E. L. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b02113 · Cited by 471
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Wang, S.-W., Gao, C., Zheng, Y.-M., Yi, L., Lu, J.-C., Huang, X.-Y., Cai, J.-B., Zhang, P.-F., Cui, Y.-H., & Ke, A.-W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01518-8 · Cited by 478
DeWitt, M. A., Magis, W., Bray, N. L., Wang, T., Berman, J. R., Urbinati, F., Heo, S.-J., Mitros, T., Muñoz, D. P., Boffelli, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9336 · Cited by 477
“The recent development of CRISPR-Cas9, a programmable RNA-guided DNA endonuclease, has ignited an explosion of interest in gene editing to cure many genetic disorders, including SCD (23, 24).”
BackgroundChemically induced proximity in biology and medicine
Stanton, B. Z., Chory, E. J., & Crabtree, G. R. (2018) · Science · doi:10.1126/science.aao5902 · Cited by 475
“(B) CIPs have been developed for rapid induction of transcriptional activation (VP16) and repression (KRAB or HP1) using DNA binding domains (DBDs) as well as CIP of split–CRISPR-Cas proteins or CIP recruitment of activators or repressors through CRISPR-Cas9 systems.”
BackgroundRaj, B., & Blencowe, B. J. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.004 · Cited by 475
“Moreover, the advent of CRISPR/Cas9 genome editing (Doudna and Charpentier, 2014; Hsu et al., 2014) has provided a powerful means with which to genetically delete or insert exons of interest in cell culture or whole animal models to systematically examine functions of neural isoforms.”
BackgroundCRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Cullot, G., Boutin, J., Toutain, J., Prat, F., Pennamen, P., Rooryck, C., Teichmann, M., Rousseau, E., Lamrissi-Garcia, I., Guyonnet-Duperat, V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09006-2 · Cited by 474
Variation in the flowering gene SELF PRUNING 5G promotes day-neutrality and early yield in tomato
Soyk, S., Müller, N. A., Park, S. J., Schmalenbach, I., Jiang, K., Hayama, R., Zhang, L., Van Eck, J., Jiménez-Gómez, J. M., & Lippman, Z. B. (2017) · Nature Genetics · doi:10.1038/ng.3733 · Cited by 461
Efficient CRISPR/Cas9-mediated Targeted Mutagenesis in Populus in the First Generation
Fan, D., Liu, T., Li, C., Jiao, B., Li, S., Hou, Y., & Luo, K. (2015) · Scientific Reports · doi:10.1038/srep12217 · Cited by 455
Methanogens: biochemical background and biotechnological applications
Enzmann, F., Mayer, F., Rother, M., & Holtmann, D. (2018) · AMB Express · doi:10.1186/s13568-017-0531-x · Cited by 437
“The recent successful -and highly efficient- application of the CRISPR/Cas9-system from Streptococcus pyogenes (Doudna and Charpentier 2014) for gene deletion and insertion in M.”
BackgroundLiquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Kantor, A., McClements, M., & MacLaren, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176240 · Cited by 462
“The recent discovery of the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system has revolutionized the field of molecular biology and medicine [1].”
BackgroundApoE4: an emerging therapeutic target for Alzheimer’s disease
Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1299-4 · Cited by 449
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Self-citationMapping the genomic landscape of CRISPR-Cas9 cleavage
Cameron, P., Fuller, C. K., Donohoue, P. D., Jones, B. N., Thompson, M. S., Carter, M. M., Gradia, S., Vidal, B., Garner, E., Slorach, E. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4284 · Cited by 443
The mammalian ribo-interactome reveals ribosome functional diversity and heterogeneity
Simsek, D., Tiu, G. C., Flynn, R. A., Byeon, G. W., Leppek, K., Xu, A. F., Chang, H. Y., & Barna, M. (2017) · Cell · doi:10.1016/j.cell.2017.05.022 · Cited by 439
“Genome editing of E14 ESCs were achieved by using CRISPR/Cas9 nuclease-mediated recombination (Doudna and Charpentier, 2014). sgRNA guide sequences were cloned into the BbsI-digested expression plasmid bearing both sgRNA scaffold backbone (BB) and Cas9 nuclease, pX330-U6-Chimeric_BB-CBh-hSpCas9…”
MethodAn APOBEC3A-Cas9 base editor with minimized bystander and off-target activities
Gehrke, J. M., Cervantes, O., Clement, M. K., Wu, Y., Zeng, J., Bauer, D. E., Pinello, L., & Joung, J. K. (2018) · Nature Biotechnology · doi:10.1038/nbt.4199 · Cited by 438
CRISPR/Cas9-induced knockout and knock-in mutations in Chlamydomonas reinhardtii
Shin, S.-E., Lim, J.-M., Koh, H. G., Kim, E. K., Kang, N. K., Jeon, S., Kwon, S., Shin, W.-S., Lee, B., Hwangbo, K., et al. (2016) · Scientific Reports · doi:10.1038/srep27810 · Cited by 423
Clinical experiences with systemically administered siRNA-based therapeutics in cancer
Zuckerman, J. E., & Davis, M. E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4685 · Cited by 424
Nanoparticle elasticity directs tumor uptake
Guo, P., Liu, D., Subramanyam, K., Wang, B., Yang, J., Huang, J., Auguste, D. T., & Moses, M. A. (2018) · Nature Communications · doi:10.1038/s41467-017-02588-9 · Cited by 421
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Zhang, S., Shen, J., Li, D., & Cheng, Y. (2021) · Theranostics · doi:10.7150/thno.47007 · Cited by 430
Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs
Port, F., & Bullock, S. L. (2016) · Nature Methods · doi:10.1038/nmeth.3972 · Cited by 437
Nucleosomes impede Cas9 access to DNA in vivo and in vitro
Horlbeck, M. A., Witkowsky, L. B., Guglielmi, B., Replogle, J. M., Gilbert, L. A., Villalta, J. E., Torigoe, S. E., Tjian, R., & Weissman, J. S. (2016) · eLife · doi:10.7554/elife.12677 · Cited by 415
“Most notably, the CRISPRassociated Cas9 protein from Streptococcus pyogenes, together with a single chimeric guide RNA (sgRNA), provides a programmable endonuclease that has revolutionized our ability to edit genomes (Doudna and Charpentier, 2014).”
Fukao, T., Barrera-Figueroa, B. E., Juntawong, P., & Peña-Castro, J. M. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00340 · Cited by 401
Qiu, M., Glass, Z., Chen, J., Haas, M., Jin, X., Zhao, X., Rui, X., Ye, Z., Li, Y., Zhang, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020401118 · Cited by 409
“These DSBs are then repaired either by nonhomologous end joining or homology directed repair (13, 14).”
BackgroundAdvances in genome editing through control of DNA repair pathways
Yeh, C. D., Richardson, C. D., & Corn, J. E. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0425-z · Cited by 405
Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells
Ma, Y., Zhang, J., Yin, W., Zhang, Z., Song, Y., & Chang, X. (2016) · Nature Methods · doi:10.1038/nmeth.4027 · Cited by 418
Overcoming Endosomal Entrapment in Drug Delivery
Pei, D., & Buyanova, M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 402
Genome Engineering with CRISPR-Cas9 in the Mosquito Aedes aegypti
Kistler, K. E., Vosshall, L. B., & Matthews, B. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.009 · Cited by 403
Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies
Aman, R., Mahas, A., & Mahfouz, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00507 · Cited by 409
Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems
Papikian, A., Liu, W., Gallego-Bartolomé, J., & Jacobsen, S. E. (2019) · Nature Communications · doi:10.1038/s41467-019-08736-7 · Cited by 395
Gibberellin Localization and Transport in Plants
Binenbaum, J., Weinstain, R., & Shani, E. (2018) · Trends in Plant Science · doi:10.1016/j.tplants.2018.02.005 · Cited by 401
Adoptive cellular therapy: A race to the finish line
June, C. H., Riddell, S. R., & Schumacher, T. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3643 · Cited by 403
“Zinc-f nger nucleases (ZFNs) and transcription activator–like ef ector nucleases (TALENS) that rely on customized DNA binding proteins, and the natural bacterial CRISPR-Cas9 system of RNA-guided nucleases, can introduce DNA double-strand breaks at specif c sites and lead to disruption of a gene sequence or provide a s…”
BackgroundRees, H. A., Komor, A. C., Yeh, W.-H., Caetano-Lopes, J., Warman, M., Edge, A. S. B., & Liu, D. R. (2017) · Nature Communications · doi:10.1038/ncomms15790 · Cited by 412
Synthetic DNA Synthesis and Assembly: Putting the Synthetic in Synthetic Biology
Hughes, R. A., & Ellington, A. D. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023812 · Cited by 411
CRISPR-Cas12a: Functional overview and applications
Paul, B., & Montoya, G. (2020) · Biomedical Journal · doi:10.1016/j.bj.2019.10.005 · Cited by 409
“Additionally, Cas12a also possesses an RNA processing site [1,9,24,31,34,37].”
BackgroundExpanding the Biologist’s Toolkit with CRISPR-Cas9
Sternberg, S. H., & Doudna, J. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.032 · Cited by 404
“We encourage the reader to consult the recent literature for more comprehensive reviews (Doudna and Charpentier, 2014; Hsu et al., 2014; Mali et al., 2013b).”
BackgroundSelf-citationYang, X., Tang, Q., Jiang, Y., Zhang, M., Wang, M., & Mao, L. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11996 · Cited by 403
Applications of the CRISPR-Cas9 system in cancer biology
Sánchez-Rivera, F. J., & Jacks, T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3950 · Cited by 405
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Liu, X., Zhang, Y., Cheng, C., Cheng, A. W., Zhang, X., Li, N., Xia, C., Wei, X., Liu, X., & Wang, H. (2017) · Cell Research · doi:10.1038/cr.2016.142 · Cited by 396
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
Beneke, T., Madden, R., Makin, L., Valli, J., Sunter, J., & Gluenz, E. (2017) · Royal Society Open Science · doi:10.1098/rsos.170095 · Cited by 394
“Genome editing by clustered regularly interspaced short palindromic repeats (CRISPR), CRISPRassociated gene 9 (Cas9) is a transformative new technology [15,16] for precise cleavage of doublestranded DNA by a Cas9 nuclease with sequence-specificity determined by a single-guide RNA (sgRNA).”
Microbial Pigments in the Food Industry—Challenges and the Way Forward
Sen, T., Barrow, C. J., & Deshmukh, S. K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00007 · Cited by 367
Pan, C., Ye, L., Qin, L., Liu, X., He, Y., Wang, J., Chen, L., & Lu, G. (2016) · Scientific Reports · doi:10.1038/srep24765 · Cited by 375
Stem Cell Models of Human Brain Development
Kelava, I., & Lancaster, M. A. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.022 · Cited by 378
WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system
Wong, N., Liu, W., & Wang, X. (2015) · Genome Biology · doi:10.1186/s13059-015-0784-0 · Cited by 374
Vitamin C Content in Fruits: Biosynthesis and Regulation
Fenech, M., Amaya, I., Valpuesta, V., & Botella, M. A. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2018.02006 · Cited by 355
Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids
Petermann, E., Lan, L., & Zou, L. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00474-x · Cited by 372
Statistical Inference as Severe Testing: How to Get Beyond the Statistics Wars
Mayo, D. G. (2018) · doi:10.1017/9781107286184 · Cited by 376
A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families
Vyas, V. K., Barrasa, M. I., & Fink, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500248 · Cited by 362
Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure
Müller, T., Dewitz, C., Schmitz, J., Schröder, A. S., Bräsen, J. H., Stockwell, B. R., Murphy, J. M., Kunzendorf, U., & Krautwald, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2547-4 · Cited by 357
“Therefore, we disrupted this gene using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-based genomeediting technology [18].”
MethodTraxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4170 · Cited by 366
CRISPR/cas9 genome editing in wheat
Kim, D., Alptekin, B., & Budak, H. (2018) · Functional & Integrative Genomics · doi:10.1007/s10142-017-0572-x · Cited by 365
The emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes-McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 341
Dynamics of CRISPR-Cas9 genome interrogation in living cells
Knight, S. C., Xie, L., Deng, W., Guglielmi, B., Witkowsky, L. B., Bosanac, L., Zhang, E. T., El Beheiry, M., Masson, J.-B., Dahan, M., et al. (2015) · Science · doi:10.1126/science.aac6572 · Cited by 356
Self-citationA CRISPR–Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection
Zhou, W., Hu, L., Ying, L., Zhao, Z., Chu, P. K., & Yu, X.-F. (2018) · Nature Communications · doi:10.1038/s41467-018-07324-5 · Cited by 358
Gu, W., Crawford, E. D., O’Donovan, B. D., Wilson, M. R., Chow, E. D., Retallack, H., & DeRisi, J. L. (2016) · Genome Biology · doi:10.1186/s13059-016-0904-5 · Cited by 358
“When coupled with single guide RNAs (sgRNAs) designed against targets of interest, S. pyogenes Cas9 binds to 3’ NGG protospacer adjacent motif (PAM) sites and produces double stranded breaks if the sgRNA successfully hybridizes with the adjacent target sequence (Figure 1A).”
CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter
Choudhury, S. R., Cui, Y., Lubecka, K., Stefanska, B., & Irudayaraj, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10234 · Cited by 353
“Recently, CRISPRCas9 (clustered, regularly interspaced, short palindromic repeat-CRISPR associated protein) mediated engineering tools have gained attention of synthetic biologists for their facile yet efficient endogenous genome editing properties [21].”
BackgroundA critical review on exploiting the pharmaceutical potential of plant endophytic fungi
Gupta, S., Chaturvedi, P., Kulkarni, M. G., & Van Staden, J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107462 · Cited by 346
Reduced Drought Tolerance by CRISPR/Cas9-Mediated SlMAPK3 Mutagenesis in Tomato Plants
Wang, L., Chen, L., Li, R., Zhao, R., Yang, M., Sheng, J., & Shen, L. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02745 · Cited by 350
CRISPR-Cas9 system: A new-fangled dawn in gene editing
Gupta, D., Bhattacharjee, O., Mandal, D., Sen, M. K., Dey, D., Dasgupta, A., Kazi, T. A., Gupta, R., Sinharoy, S., Acharya, K., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116636 · Cited by 323
Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems
O'Connell, M. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.029 · Cited by 346
Wang, D., Mou, H., Li, S., Li, Y., Hough, S., Tran, K., Li, J., Yin, H., Anderson, D. G., Sontheimer, E. J., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.087 · Cited by 345
Origins of Programmable Nucleases for Genome Engineering
Chandrasegaran, S., & Carroll, D. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.10.014 · Cited by 325
“Several excellent recent reviews describing the discovery of adaptive immunity in bacteria and the development of CRISPR-Cas9 for genome engineering are available in literature [93-96].”
Mechanisms and clinical importance of bacteriophage resistance
Egido, J. E., Costa, A. R., Aparicio-Maldonado, C., Haas, P.-J., & Brouns, S. J. J. (2022) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab048 · Cited by 325
“Of the six types described so far, type II is the best-known due to its applications for genome editing technology (Doudna and Charpentier 2014).”
BackgroundSchiroli, G., Conti, A., Ferrari, S., della Volpe, L., Jacob, A., Albano, L., Beretta, S., Calabria, A., Vavassori, V., Gasparini, P., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.02.019 · Cited by 342
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
He, X., Tan, C., Wang, F., Wang, Y., Zhou, R., Cui, D., You, W., Zhao, H., Ren, J., & Feng, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw064 · Cited by 338
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems
Leenay, R. T., Maksimchuk, K. R., Slotkowski, R. A., Agrawal, R. N., Gomaa, A. A., Briner, A. E., Barrangou, R., & Beisel, C. L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.031 · Cited by 336
“…Repeats) and their associated Cas (CRISPR associated) proteins form widespread adaptive immune systems in prokaryotes that have been harnessed as ubiquitous tools in biotechnology and medicine (Barrangou et al., 2007; Doudna and Charpentier, 2014; Hsu et al., 2014; van der Oost et al., 2014).”
BackgroundComplex transcriptional modulation with orthogonal and inducible dCas9 regulators
Gao, Y., Xiong, X., Wong, S., Charles, E. J., Lim, W. A., & Qi, L. S. (2016) · Nature Methods · doi:10.1038/nmeth.4042 · Cited by 329
Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332
Illuminating the dark phosphoproteome
Needham, E. J., Parker, B. L., Burykin, T., James, D. E., & Humphrey, S. J. (2019) · Science Signaling · doi:10.1126/scisignal.aau8645 · Cited by 334
“Innovative genome editing tools (112, 113) may also unlock methods to systematically explore the functional consequences of global phosphorylation.”
BackgroundCalero, P., & Nikel, P. I. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13292 · Cited by 330
“More recently, the adoption of techniques based on clustered regulatory interspaced short palindromic repeats (CRISPR) in association with Cas9-based counter selection systems for genome editing (Jiang et al., 2013, 2015; Doudna and Charpentier, 2014), deactivated Cas9 protein for targeted gene regulation (CRISPRi, CR…”
BackgroundMethodMachine learning for metabolic engineering: A review
Lawson, C. E., Martí, J. M., Radivojevic, T., Jonnalagadda, S. V. R., Gentz, R., Hillson, N. J., Peisert, S., Kim, J., Simmons, B. A., Petzold, C. J., et al. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2020.10.005 · Cited by 313
Controlling vector-borne diseases by releasing modified mosquitoes
Flores, H. A., & O’Neill, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0025-0 · Cited by 315
Bioremediation through microbes: systems biology and metabolic engineering approach
Dangi, A. K., Sharma, B., Hill, R. T., & Shukla, P. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2018.1500997 · Cited by 318
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Buck, J., Grossen, P., Cullis, P. R., Huwyler, J., & Witzigmann, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b07858 · Cited by 312
Nguyen, D. N., Roth, T. L., Li, P. J., Chen, P. A., Apathy, R., Mamedov, M. R., Vo, L. T., Tobin, V. R., Goodman, D., Shifrut, E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0325-6 · Cited by 312
Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications
Matoba, S., & Zhang, Y. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.018 · Cited by 307
iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
Ali, Z., Aman, R., Mahas, A., Rao, G. S., Tehseen, M., Marsic, T., Salunke, R., Subudhi, A. K., Hala, S. M., Hamdan, S. M., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198129 · Cited by 310
“These systems have been used to engineer the genomes and transcriptomes of all transformable species (Mahas et al., 2019; Doudna and Charpentier, 2014; Mahas et al., 2017).”
MethodJia, H., Orbovic, V., Jones, J. B., & Wang, N. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12495 · Cited by 309
CRISPR–Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters
Zhang, M. M., Wong, F. T., Wang, Y., Luo, S., Lim, Y. H., Heng, E., Yeo, W. L., Cobb, R. E., Enghiad, B., Ang, E. L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2341 · Cited by 304
A machine learning Automated Recommendation Tool for synthetic biology
Radivojević, T., Costello, Z., Workman, K., & Garcia Martin, H. (2020) · Nature Communications · doi:10.1038/s41467-020-18008-4 · Cited by 277
Sago, C. D., Lokugamage, M. P., Paunovska, K., Vanover, D. A., Monaco, C. M., Shah, N. N., Gamboa Castro, M., Anderson, S. E., Rudoltz, T. G., Lando, G. N., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811276115 · Cited by 313
Chemistries of bifunctional PROTAC degraders
Cao, C., He, M., Wang, L., He, Y., & Rao, Y. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00220e · Cited by 313
Rapid and Fully Microfluidic Ebola Virus Detection with CRISPR-Cas13a
Qin, P., Park, M., Alfson, K. J., Tamhankar, M., Carrion, R., Patterson, J. L., Griffiths, A., He, Q., Yildiz, A., Mathies, R., et al. (2019) · ACS Sensors · doi:10.1021/acssensors.9b00239 · Cited by 311
Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
Wilbie, D., Walther, J., & Mastrobattista, E. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00106 · Cited by 294
A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae
Reider Apel, A., d'Espaux, L., Wehrs, M., Sachs, D., Li, R. A., Tong, G. J., Garber, M., Nnadi, O., Zhuang, W., Hillson, N. J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1023 · Cited by 306
“The DSB can be repaired by homologous recombination (HR), allowing for marker-less disruption, deletion or insertion (5).”
Advanced hybrid nanomaterials for biomedical applications
Park, W., Shin, H., Choi, B., Rhim, W.-K., Na, K., & Keun Han, D. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100686 · Cited by 299
The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2
Davidovich, C., & Cech, T. R. (2015) · RNA · doi:10.1261/rna.053918.115 · Cited by 295
“In the future, site-specific genome editing techniques could be used to test these mutations in vivo (Doudna and Charpentier 2014; Hsu et al. 2014; Sander and Joung 2014), assaying for changes in PRC2 recruitment and gene silencing.”
BackgroundPost-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F., & Chin, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.019 · Cited by 299
The genome editing revolution: review
Khalil, A. M. (2020) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-020-00078-y · Cited by 273
“In addition, the role of CRISPRs as bacterial and archaeal adaptive immunity system against invading bacteriophages and other and in DNA repair was realized [17, 77].”
BackgroundSynthetic biology 2020–2030: six commercially-available products that are changing our world
Voigt, C. A. (2020) · Nature Communications · doi:10.1038/s41467-020-20122-2 · Cited by 294
Laughery, M. F., Hunter, T., Brown, A., Hoopes, J., Ostbye, T., Shumaker, T., & Wyrick, J. J. (2015) · Yeast · doi:10.1002/yea.3098 · Cited by 306
“…key advance was the discovery that a hybrid ’single guide’ RNA (sgRNA) that fuses the crRNA guide sequence to the tracrRNA can be used for efficient Cas9 targeting (Jinek et al., 2012) in a plethora of different organisms (Doudna and Charpentier, 2014; Hsu et al., 2014; Sternberg and Doudna, 2015).”
BackgroundMethodGaussian accelerated molecular dynamics: Principles and applications
Wang, J., Arantes, P. R., Bhattarai, A., Hsu, R. V., Pawnikar, S., Huang, Y. M., Palermo, G., & Miao, Y. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1521 · Cited by 295
“CRISPR–Cas9 system is a bacterial immune system that has introduced a powerful genome-editing technology, which has revolutionized life sciences.(108) At the molecular level, CRISPR-Cas9 is a protein/nucleic acid complex, composed of the Cas9 protein associated with a guide RNA and matching sequences of DNA.”
BackgroundCRISPR Crops: Plant Genome Editing Toward Disease Resistance
Langner, T., Kamoun, S., & Belhaj, K. (2018) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-050158 · Cited by 281
“However, some factors such as PAM specificity, rational design of the sgRNA, and off-target activity can limit its efficiency and specificity (20, 62, 191, 242).”
BackgroundInfluentialCloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice
Aida, T., Chiyo, K., Usami, T., Ishikubo, H., Imahashi, R., Wada, Y., Tanaka, K. F., Sakuma, T., Yamamoto, T., & Tanaka, K. (2015) · Genome Biology · doi:10.1186/s13059-015-0653-x · Cited by 296
“The CRISPR/Cas system consisting of two components - Cas9 nuclease and sgRNA - is the most common approach in the field of genome editing due to its enhanced convenience and robust targeting [15].”
BackgroundSmall-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.